Acoziborole could change that. The new drug works for both early and advanced stages of the most common form of sleeping ...

For use outside the EU, the regulator backed a single-dose oral approach that treats all stages and could spare patients ...

On February 27, 2026, the EMA’s Committee for Medicinal Products for Human Use recommended acoziborole for treating early and ...

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has granted a positive opinion to Acoziborole Winthrop (acoziborole) as a single-dose oral treatment for both ...

Acoziborole Winthrop, developed by DNDi and Sanofi, receives CHMP positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness Recommendation based on phase 2/3 ...

For decades, treating the deadly neglected disease meant painful injections and long hospital stays. Now, a one-day oral ...

Even though insects are small, we shouldn’t overlook the venomous and serious threats that some of them pose to human life and health. They can kill or even lead an individual into coma through their ...

This week in Africa: a potential breakthrough in the fight against sleeping sickness with a single-dose oral treatment, alongside a $1.2 billion health agreement between the DRC and the United States.

A single-dose pill called acoziborole cured most sleeping sickness patients in a major trial, even when the parasite reached the brain.

European drug regulators on Friday endorsed a new and simpler treatment for sleeping sickness, in what could be a giant boost ...

The investigative minds at How to Survive outline precautions during a sleeping sickness outbreak devastating a village. Trump v. Trump. Which president shows up at the State of the Union? Heavy snow ...